| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From University of California, San Francisco.
Address correspondence and reprint requests to Dr. Bruce A.C. Cree, Multiple Sclerosis Center at UCSF, 350 Parnassus Ave., Suite 908, San Francisco, CA 94117; e-mail: bcree{at}itsa.ucsf.edu
Eight patients with worsening neuromyelitis optica were treated with rituximab to achieve B cell depletion. Treatment was well tolerated. Six of eight patients were relapse free and median attack rate declined from 2.6 attacks/patient/year to 0 attacks/patient/year (p = 0.0078). Seven of eight patients experienced substantial recovery of neurologic function over 1 year of average follow-up. The pretreatment median Expanded Disability Status Scale score was 7.5, and at follow-up examination was 5.5 (p = 0.013).
Bruce Cree’s contribution was supported in part by the Sylvia Lawry postdoctoral fellowship grant from the National Multiple Sclerosis Society.
Received December 30, 2004. Accepted in final form January 30, 2005.
This article has been cited by other articles:
|
|
 |
|
  P Cabre, A Gonzalez-Quevedo, M Bonnan, A Saiz, S Olindo, F Graus, D Smadja, H Merle, L Thomas, and J A Cabrera-Gomez Relapsing neuromyelitis optica: long term history and clinical predictors of death J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1162 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jacob, M. Matiello, B. G. Weinshenker, D. M. Wingerchuk, C. Lucchinetti, E. Shuster, J. Carter, B. M. Keegan, O. H. Kantarci, and S. J. Pittock Treatment of Neuromyelitis Optica With Mycophenolate Mofetil: Retrospective Analysis of 24 Patients Arch Neurol, September 1, 2009; 66(9): 1128 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. McKeon, J. P. Fryer, M. Apiwattanakul, V. A. Lennon, S. R. Hinson, T. J. Kryzer, C. F. Lucchinetti, B. G. Weinshenker, D. M. Wingerchuk, E. A. Shuster, et al. Diagnosis of Neuromyelitis Spectrum Disorders: Comparative Sensitivities and Specificities of Immunohistochemical and Immunoprecipitation Assays Arch Neurol, September 1, 2009; 66(9): 1134 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nasir, D. A. Kerr, and J. Birnbaum Nineteen Episodes of Recurrent Myelitis in a Woman With Neuromyelitis Optica and Systemic Lupus Erythematosus Arch Neurol, September 1, 2009; 66(9): 1160 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Viegas, A Weir, M Esiri, W Kuker, P Waters, M I Leite, A Vincent, and J Palace Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica J. Neurol. Neurosurg. Psychiatry, June 1, 2009; 80(6): 679 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Bonnan, R Valentino, S Olindo, H Mehdaoui, D Smadja, and P Cabre Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder Multiple Sclerosis, April 1, 2009; 15(4): 487 - 492. [Abstract] [PDF]
|
|
|
|
 |
|
 E. C. Klawiter, E. Alvarez III, J. Xu, A. R. Paciorkowski, L. Zhu, B. J. Parks, A. H. Cross, and R. T. Naismith NMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICA Neurology, March 24, 2009; 72(12): 1101 - 1103. [Full Text] [PDF]
|
|
|
|
|
|
H. Petereit and A Rubbert-Roth Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders Multiple Sclerosis, February 1, 2009; 15(2): 189 - 192. [Abstract] [PDF]
|
|
|
|
 |
|
 D E Furst, E C Keystone, B Kirkham, R Fleischmann, P Mease, F C Breedveld, J S Smolen, J R Kalden, G R Burmester, J Braun, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii2 - iii25. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jarius, F. Aboul-Enein, P. Waters, B. Kuenz, A. Hauser, T. Berger, W. Lang, M. Reindl, A. Vincent, and W. Kristoferitsch Antibody to aquaporin-4 in the long-term course of neuromyelitis optica Brain, November 1, 2008; 131(11): 3072 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jacob, B. G. Weinshenker, I. Violich, N. McLinskey, L. Krupp, R. J. Fox, D. M. Wingerchuk, M. Boggild, C. S. Constantinescu, A. Miller, et al. Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients Arch Neurol, November 1, 2008; 65(11): 1443 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Lotze, J. L. Northrop, G. J. Hutton, B. Ross, J. S. Schiffman, and J. V. Hunter Spectrum of Pediatric Neuromyelitis Optica Pediatrics, November 1, 2008; 122(5): e1039 - e1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Jarius, D Franciotta, R Bergamaschi, S Rauer, K P Wandinger, H F Petereit, M Maurer, H Tumani, A Vincent, P Eichhorn, et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1134 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Novak, A. E. Lovett-Racke, and M. K. Racke Monoclonal Antibody Therapies and Neurologic Disorders Arch Neurol, September 1, 2008; 65(9): 1162 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, et al. CNS aquaporin-4 autoimmunity in children Neurology, July 8, 2008; 71(2): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Linker and B. C. Kieseier Review: Innovative monoclonal antibody therapies in multiple sclerosis Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 33 - 42. [Abstract] [PDF]
|
|
|
|
|
|
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura Review: Treatment of neuromyelitis optica: Current debate Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 43 - 52. [Abstract] [PDF]
|
|
|
|
|
|
P. Waters, S. Jarius, E. Littleton, M. I. Leite, S. Jacob, B. Gray, R. Geraldes, T. Vale, A. Jacob, J. Palace, et al. Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis Arch Neurol, July 1, 2008; 65(7): 913 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. de Seze, F. Blanc, L. Jeanjean, H. Zephir, P. Labauge, M. Bouyon, L. Ballonzoli, G. Castelnovo, M. Fleury, S. Defoort, et al. Optical Coherence Tomography in Neuromyelitis Optica Arch Neurol, July 1, 2008; 65(7): 920 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Moreh, I Gartsman, D Karussis, D Rund, N Hiller, and Z Meiner Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment Multiple Sclerosis, July 1, 2008; 14(6): 860 - 861. [PDF]
|
|
|
|
|
|
M. C. Dalakas Invited Article: Inhibition of B cell functions: Implications for neurology Neurology, June 3, 2008; 70(23): 2252 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krumbholz, H. Faber, F. Steinmeyer, L.-A. Hoffmann, T. Kumpfel, H. Pellkofer, T. Derfuss, C. Ionescu, M. Starck, C. Hafner, et al. Interferon-{beta} increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity Brain, June 1, 2008; 131(6): 1455 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock and V. A. Lennon Aquaporin-4 Autoantibodies in a Paraneoplastic Context Arch Neurol, May 1, 2008; 65(5): 629 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R Mehta, M. K Samuelsson, A. K Kleiner, A. D Goodman, J. H Anolik, R J. Looney, and S. R Schwid Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome Multiple Sclerosis, April 1, 2008; 14(3): 425 - 427. [Abstract] [PDF]
|
|
|
|
|
|
R. A Wilcox, J. Burrow, M. Slee, J. Craig, and D. Thyagarajan Neuromyelitis optica (Devic's disease) in a patient with syphilis Multiple Sclerosis, March 1, 2008; 14(2): 268 - 271. [Abstract] [PDF]
|
|
|
|
|
|
M. Levy, J. Birnbaum, and D. Kerr Finding NMO: Neuromyelitis optica in children Neurology, January 29, 2008; 70(5): 334 - 335. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, V. A. Lennon, J. de Seze, P. Vermersch, H. A. Homburger, D. M. Wingerchuk, C. F. Lucchinetti, H. Zephir, K. Moder, and B. G. Weinshenker Neuromyelitis Optica and Non Organ-Specific Autoimmunity Arch Neurol, January 1, 2008; 65(1): 78 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Blanc, H. Zephir, C. Lebrun, P. Labauge, G. Castelnovo, M. Fleury, F. Sellal, C. Tranchant, K. Dujardin, P. Vermersch, et al. Cognitive Functions in Neuromyelitis Optica Arch Neurol, January 1, 2008; 65(1): 84 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Glisson and S. L. Galetta Is Neuromyelitis Optica Eyeing a Distinct Path From Multiple Sclerosis? Arch Ophthalmol, January 1, 2008; 126(1): 128 - 129. [Full Text] [PDF]
|
|
|
|
|
|
S. R. Hinson, S. J. Pittock, C. F. Lucchinetti, S. F. Roemer, J. P. Fryer, T. J. Kryzer, and V. A. Lennon Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica Neurology, December 11, 2007; 69(24): 2221 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Yu, C. Z. Zhu, K. C. Li, Y. Xuan, W. Qin, H. Sun, and P. Chan Relapsing Neuromyelitis Optica and Relapsing-Remitting Multiple Sclerosis: Differentiation at Diffusion-Tensor MR Imaging of Corpus Callosum Radiology, July 1, 2007; 244(1): 249 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Frohman and D. Kerr Is Neuromyelitis Optica Distinct From Multiple Sclerosis?: Something for "Lumpers" and "Splitters" Arch Neurol, June 1, 2007; 64(6): 903 - 905. [Full Text] [PDF]
|
|
|
|
|
|
G.J.D. Hengstman, P. Wesseling, C.W.G.M. Frenken, and P.J.H. Jongen Neuromyelitis optica with clinical and histopathological involvement of the brain Multiple Sclerosis, June 1, 2007; 13(5): 679 - 682. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H. J. Kim, and A. Bar-Or Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis J. Immunol., May 15, 2007; 178(10): 6092 - 6099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pohl, E. Waubant, B. Banwell, D. Chabas, T. Chitnis, B. Weinstock-Guttman, S. Tenembaum, and for the International Pediatric MS Study Group Treatment of pediatric multiple sclerosis and variants Neurology, April 17, 2007; 68(16_suppl_2): S54 - S65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Choudry and J. W. Chan An Update on Monoclonal Antibody Therapies in Multiple Sclerosis Journal of Pharmacy Practice, April 1, 2007; 20(2): 167 - 180. [Abstract] [PDF]
|
|
|
|
|
|
C Papeix, J-S Vidal, J de Seze, C Pierrot-Deseilligny, A Tourbah, B Stankoff, C Lebrun, T Moreau, P Vermersch, B Fontaine, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica Multiple Sclerosis, March 1, 2007; 13(2): 256 - 259. [Abstract] [PDF]
|
|
|
|
|
|
T Fukazawa and S Kikuchi A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the 'attack-related severity' axis Multiple Sclerosis, March 1, 2007; 13(2): 199 - 207. [Abstract] [PDF]
|
|
|
|
|
|
T. F. Scott, S. L. Kassab, and S. J. Pittock Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol, October 1, 2006; 63(10): 1398 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Lalive, T. Menge, I. Barman, B. A. Cree, and C. P. Genain Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology, July 11, 2006; 67(1): 176 - 177. [Full Text] [PDF]
|
|
|
|
|
|
B. Weinstock-Guttman, M. Ramanathan, N. Lincoff, S. Q. Napoli, J. Sharma, J. Feichter, and R. Bakshi Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (devic disease). Arch Neurol, July 1, 2006; 63(7): 957 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, B. G. Weinshenker, C. F. Lucchinetti, D. M. Wingerchuk, J. R. Corboy, and V. A. Lennon Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol, July 1, 2006; 63(7): 964 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Kerr The lumping and splitting of inflammatory CNS diseases Neurology, May 23, 2006; 66(10): 1466 - 1467. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker Revised diagnostic criteria for neuromyelitis optica Neurology, May 23, 2006; 66(10): 1485 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pittock, V. A. Lennon, K. Krecke, D. M. Wingerchuk, C. F. Lucchinetti, and B. G. Weinshenker Brain abnormalities in neuromyelitis optica. Arch Neurol, March 1, 2006; 63(3): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Carter B Cells in Health and Disease Mayo Clin. Proc., March 1, 2006; 81(3): 377 - 384. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
